PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nordmann JP et al. – Reported compliance rates were very high and similar across groups during both treatment periods. After 1 month of use during both treatment periods, more than 70% of subjects reported global satisfaction with Xal–Ease to their physicians. No adverse events associated with the use of Xal–Ease were noted. Xal–Ease generally makes administration of latanoprost or fixed–combination latanoprost/timolol easier compared with the dropper bottle.

   

Today in Ophthalmology...keeping you current

A novel genetic variant of BMP2K contributes to high myopia
Journal of Clinical Laboratory Analysis, 12/07/09

Can central hexagon peak latency provide a clue to fixation within the mfERG
Documenta Ophthalmologica, 12/07/09

Advances in glaucoma surgery
Expert Review of Ophthalmology, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address